Search results for "Pfizer vaccination"

Witness Testimony Keywords from Transcript Pfizer vaccination, kidney failure, dense deposit disease, Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Severe kidney failure following Pfizer COVID-19 vaccination, transplant eligibility complications, and observed post-vaccination embalming embalmer with approximately 15 years of experience, testified that she received a first dose of the Pfizer COVID-19 vaccine in April 2021 for occupational and family protection.

Ultimatum, Autonomy Loss, Anxiety and Trauma, Graves’ Disease Disclosure, Pharmacist Administration, Pfizer Vaccine, Lot FF5109, Independent Grocer Hubbards, Spousal Vaccine Injury, Pulmonary Embolism (Spouse Line Summary Public service coordinator Tami Clarke testified that she felt compelled to receive two Pfizer , she was required under provincial mandate to be vaccinated to retain her employment. Clarke received her first Pfizer dose on November 24, 2021 (lot FF5109) and her second dose on January

Witness Testimony Keywords from Transcript Moderna vaccine reaction, Pfizer second dose, POTS diagnosis V Leiden, Alberta Health Services, adverse event dispute, chronic disability, mobility impairment, vaccine injury program, cardiology referral, post-vaccination symptoms Included in the Report: Ms. , stating her reaction was not vaccine-related. She received a Pfizer vaccine in January 2022, after which she described a significant worsening of symptoms

Witness Testimony Keywords from Transcript Pfizer Vaccine (Single Dose), Lot FA9093, Burning Leg Pain John’s, Newfoundland, and received one dose of the Pfizer COVID-19 vaccine on June 18, 2021 in order She stated she was apprehensive prior to vaccination and reported that risks were not discussed beyond She identified the vaccine lot number as FA9093. She reported escalating mental health symptoms following vaccination, including severe panic attacks,

Witness Testimony Keywords from Transcript Pfizer vaccine April June 2021, autoimmune reaction symptoms COVID-19 vaccination and alleged dismissal of vaccine injury by medical professionals. Synopsis Patricia Leidl testified that she received two doses of the Pfizer-BioNTech COVID-19 vaccine She further testified that attempts to file vaccine injury reports were delayed or resisted by physicians In closing, she read a written statement expressing belief that vaccine-related harms were known but

Witness Testimony Keywords from Transcript Pfizer vaccination timeline, loss of taste post-vaccine, cognitive Canada; November 2023 Main Topic Testimony describing his brother’s health decline following COVID vaccination Retired paramedic Richard Lizotte testified that his brother experienced rapid health decline after vaccination COVID-19 vaccinations in 2021. emergency, he was later informed that hospital COVID protocols prohibited any visitors, regardless of vaccination

Witness Testimony Keywords from Transcript Pfizer vaccine reaction, facial numbness onset, full-body November 2023 Main Topic Severe neurological, dermatological, and cognitive symptoms following COVID-19 vaccination Synopsis Jennifer Curry testified that she received her first Pfizer COVID-19 vaccine dose on October Within minutes of leaving the vaccination site, she experienced facial numbness that progressed to full-body She testified that she had no prior history of such symptoms and believes the vaccination precipitated

Witness Testimony Keywords from Transcript Pfizer vaccination, delayed symptom onset, systemic inflammation , Amjevita biologic, significant weight loss, functional disability, inflammatory markers elevated, vaccine 2023 Main Topic Onset of chronic systemic inflammation and functional disability following COVID-19 vaccination inflammatory illness, severe weakness, and immunosuppressive treatment beginning months after COVID vaccination She indicated that no formal link between her condition and vaccination was acknowledged by her physicians

December 9, 2020: Health Canada approves the Pfizer-BioNTech vaccine for use under an Interim Order. December 14, 2020: The first doses of the Pfizer-BioNTech vaccine are administered in Canada. May 5, 2021: The Pfizer vaccine is authorized for use in children aged 12 and up. October 30, 2021: Health Canada approves the pediatric Pfizer vaccine for children aged 5 to 11. November 9, 2021: Health Canada authorizes the use of Pfizer vaccine as a booster shot.

Critique of lockdowns and vaccine mandates, advocacy for focused protection of the vulnerable, defence Scientific and personal testimony criticizing pandemic policies, PCR testing practices, mRNA vaccine Testimony describing unpaid leave under the federal vaccine mandate for railway workers, major income Testimony describing onset of recurrent exertion-related blackouts approximately three months after a Pfizer vaccination, resulting in reduced physical capacity and ongoing occupational impairment.

by Health Canada under the Interim Order: Pfizer-BioNTech on December 9, 2020 for ages 16 and older, T-145-22 in which she described the basis of Health Canada's authorization of the Pfizer/ BioNTech and Additionally, McLeod shed light on Pfizer's historical legal issues and the broader issue of potential The reference to Pfizer's past legal issues underscores the necessity for scrutinizing the track record For example, at the top of Health Canada’s website page for the Pfizer vaccine, Health Canada states:

by Health Canada under the Interim Order: Pfizer-BioNTech on December 9, 2020 for ages 16 and older, T-145-22 in which she described the basis of Health Canada's authorization of the Pfizer/ BioNTech and Additionally, McLeod shed light on Pfizer's historical legal issues and the broader issue of potential The reference to Pfizer's past legal issues underscores the necessity for scrutinizing the track record For example, at the top of Health Canada’s website page for the Pfizer vaccine, Health Canada states: